Share Your Thoughts on our Terminology Server! Let us know your insights and help enhance our services. The survey is open from Nov 19 to Dec 3, 2024. Your feedback matters!
Learn More >
We'd like to hear your thoughts about the naming of biologic drugs including biosimilars. This questionnaire consists of 5 questions.
Access the Consultation and Questionnaire link below: lnkd.in/dZFZXc9
Your responses before February 9th, to this consultation questionnaire will help to inform the development of Health Canada's naming policy to distinguish among biologic drugs that share the same non-proprietary name.
Improving the quality of patient care through the effective sharing of clinical information among health care organizations, clinicians and their patients.
Print
Email
Naming of Biologics: We want to hear from you!
Twitter